SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 163 filers reported holding CLOVIS ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$137,000
-73.6%
115,299
-55.1%
0.00%
-80.0%
Q1 2022$519,000
-36.2%
256,919
-14.4%
0.01%
-52.4%
Q4 2021$814,000
-1.3%
300,203
+62.4%
0.02%
+40.0%
Q3 2021$825,000
+1.6%
184,904
+59.9%
0.02%
+7.1%
Q1 2021$812,000
+374.9%
115,628
+294.6%
0.01%
+180.0%
Q3 2020$171,000
-13.6%
29,3000.0%0.01%
-44.4%
Q2 2020$198,00029,3000.01%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,997,826$10,834,0000.69%
Ikarian Capital, LLC 1,112,669$3,016,0000.45%
Versant Venture Management, LLC 101,855$276,0000.15%
Virtus ETF Advisers LLC 60,836$165,0000.06%
EMFO, LLC 21,500$58,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
PINNACLE ASSOCIATES LTD 706,336$1,914,0000.03%
XTX Topco Ltd 20,920$57,0000.03%
State of Wyoming 25,419$69,0000.03%
View complete list of CLOVIS ONCOLOGY INC shareholders